Legal & General Group’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$57M Buy
198,519
+8,149
+4% +$2.34M 0.01% 596
2025
Q1
$58.7M Buy
190,370
+16,611
+10% +$5.12M 0.02% 589
2024
Q4
$61.3M Sell
173,759
-9,029
-5% -$3.19M 0.02% 585
2024
Q3
$65.5M Sell
182,788
-6,074
-3% -$2.18M 0.02% 593
2024
Q2
$60.2M Sell
188,862
-14,167
-7% -$4.51M 0.02% 591
2024
Q1
$46.6M Sell
203,029
-10,564
-5% -$2.43M 0.01% 646
2023
Q4
$47M Sell
213,593
-6,010
-3% -$1.32M 0.01% 645
2023
Q3
$49.6M Sell
219,603
-1,936
-0.9% -$437K 0.02% 632
2023
Q2
$48.9M Buy
221,539
+4,764
+2% +$1.05M 0.02% 645
2023
Q1
$48.5M Buy
216,775
+95,909
+79% +$21.5M 0.02% 630
2022
Q4
$33.6M Buy
120,866
+5,813
+5% +$1.62M 0.01% 694
2022
Q3
$24.1M Sell
115,053
-3,535
-3% -$740K 0.01% 756
2022
Q2
$27.9M Sell
118,588
-1,774
-1% -$418K 0.01% 747
2022
Q1
$21.6M Buy
120,362
+2,631
+2% +$472K 0.01% 859
2021
Q4
$25.4M Buy
117,731
+3,144
+3% +$679K 0.01% 836
2021
Q3
$21.2M Buy
114,587
+502
+0.4% +$92.7K 0.01% 872
2021
Q2
$20.5M Sell
114,085
-15,470
-12% -$2.78M 0.01% 893
2021
Q1
$21.7M Sell
129,555
-1,315
-1% -$220K 0.01% 856
2020
Q4
$19.9M Sell
130,870
-6,736
-5% -$1.02M 0.01% 848
2020
Q3
$13.9M Buy
137,606
+2,831
+2% +$286K 0.01% 894
2020
Q2
$16.3M Buy
134,775
+9,805
+8% +$1.19M 0.01% 839
2020
Q1
$11.8M Sell
124,970
-1,810
-1% -$171K 0.01% 858
2019
Q4
$11.2M Buy
126,780
+5,018
+4% +$442K 0.01% 975
2019
Q3
$9.71M Buy
121,762
+8,116
+7% +$647K 0.01% 991
2019
Q2
$8.87M Sell
113,646
-50,413
-31% -$3.94M ﹤0.01% 1015
2019
Q1
$19.3M Buy
164,059
+51,428
+46% +$6.04M 0.01% 761
2018
Q4
$12.3M Buy
112,631
+11,664
+12% +$1.27M 0.01% 792
2018
Q3
$12.9M Buy
100,967
+2,399
+2% +$307K 0.01% 809
2018
Q2
$11.2M Sell
98,568
-330
-0.3% -$37.3K 0.01% 823
2018
Q1
$11.1M Buy
98,898
+7,156
+8% +$804K 0.01% 802
2017
Q4
$13.6M Buy
91,742
+1,896
+2% +$281K 0.01% 742
2017
Q3
$10.5M Buy
89,846
+8,549
+11% +$1M 0.01% 768
2017
Q2
$10.5M Buy
81,297
+9,664
+13% +$1.25M 0.01% 752
2017
Q1
$9.7M Buy
71,633
+19,855
+38% +$2.69M 0.01% 756
2016
Q4
$7.43M Buy
51,778
+7,806
+18% +$1.12M 0.01% 788
2016
Q3
$5.19M Buy
43,972
+2,726
+7% +$322K 0.01% 776
2016
Q2
$4.37M Buy
41,246
+9,331
+29% +$988K ﹤0.01% 783
2016
Q1
$3.56M Buy
31,915
+4,313
+16% +$481K ﹤0.01% 792
2015
Q4
$4.32M Buy
27,602
+1,246
+5% +$195K ﹤0.01% 773
2015
Q3
$3.46M Buy
26,356
+4,570
+21% +$600K ﹤0.01% 800
2015
Q2
$3.79M Buy
21,786
+19,076
+704% +$3.32M ﹤0.01% 784
2015
Q1
$467K Buy
+2,710
New +$467K ﹤0.01% 1302